NCT04003636 2025-04-23KEYNOTE-966Merck Sharp & Dohme LLCPhase 3 Completed1,069 enrolled 19 charts 1 FDA
NCT02819518 2024-11-27KEYNOTE-355Merck Sharp & Dohme LLCPhase 3 Completed882 enrolled 41 charts 2 FDA
NCT03348904 2019-06-13Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung CancerIncyte CorporationPhase 3 Terminated2 enrolled 6 charts